glp 1 and digestive issues GLP-1 for Weight Loss Diabetes Crosstalk between glucagon-like peptide 1

Te recomendamos Calculadora de AARP Cun saludable es tu peso

The next wave of research has sought to capitalize on the benefits of GLP-1s with fewer downsides

Risks/ disadvantages of GLP-1 agonists: Nausea and vomiting (far less likely when starting on a very low dose and titrating up slowly) Diarrhoea Dizziness and tiredness Mild tachycardia (increased heart rate) Headaches Temporary itchiness /redness around injection sites Dry mouth/reduced salivary secretions Low blood sugar Rare but more serious side effects: Pancreatitis More serious gut side effects because of stagnated gut movement Medullary thyroid cancer Sudden kidney injury (usually because of reduced volume intake or vomiting) Worsening of diabetic retinopathy (diabetes related eye disease) Allergic reactions Gallbladder or biliary disease Depression and suicidal ideation Aspiration (food or liquid getting into lungs) during anaesthesia as the stomach empties more slowly- ideally the medication should be stopped for 2-4 weeks prior to elective surgery

Under aerobic condition, SOD overexpression boosted the growth of S-3/pKLH167, S-3/pKLH337, S-3/pKLH341, and S-3/pKLH344 with 1 mmol/L H 2 O 2 treatment compared with the control strain S-3/pKLH32 (Figure 4A)

Data from various studies also indicate that regaining weight can reverse improvements in cardiometabolic health achieved during treatment